Emergent Biosolutions's total assets for Q4 2023 were $1.82B, a decrease of -3.69% from the previous quarter. EBS total liabilities were $1.17B for the fiscal quarter, a -1.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.